Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Ubiquitination of the insulin receptor regulates collagen secretion in human skin.

Topical caffeine can help with hair growth and reduce hair loss safely.

Reducing SFRP1 can promote hair growth and may help treat hair loss.

A new 6-point scale reliably measures heat damage to hair from styling tools.

Chemotherapy and radiotherapy do not significantly affect obstructive sleep apnea development.

PLLA dermal fillers can cause hair loss, but it can be treated with steroids.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

PRP shows promise for hair and skin treatment, but more research is needed for standard practices.

Immune cells are essential for early hair and skin development and healing.

Combining robotic and specialized tools improves hair transplant results.

New treatments for hair loss include low-dose pills, updated drugs, supplements, light therapy, plasma injections, and advanced hair transplant techniques.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Using multiple treatments together works better for female hair loss than using one treatment alone.

REVIVV® serum improves hair growth and reduces shedding in androgenetic alopecia.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

High platelet numbers in PRP may not be essential for hair growth, and certain growth factors could negatively affect treatment outcomes for hair loss.

Certain polyphenols may help treat skin pigmentation disorders.

Aging-related changes in hair follicle stem cells can be partially reversed with a specific treatment.

NSG mice had the most mites, and genetic factors affect immune response and susceptibility.

FDA-cleared devices often fail to produce high-quality platelet-rich plasma consistently.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Intralesional corticosteroids are best for mild alopecia areata, and DPCP is best for severe cases.

Some alternative treatments may help with hair loss, but more evidence is needed to confirm their effectiveness.